Joel White’s op-ed about upcoming changes to Medicare Part D, due to the Inflation Reduction Act, was published in the International Business Times. The op-ed includes recently research projecting that millions of Medicare beneficiaries will see their out-of-pocket drug costs increase because of the law.
